By Dallas Weekly Staff

In recognition of National Clinical Trials Day, Alzheimer’s research centers across the United States and Canada are offering free memory screenings for adults ages 55 and older, highlighting the growing importance of brain health awareness and early detection of cognitive decline.

The nationwide initiative comes as Alzheimer’s disease continues to impact millions of families. According to organizers, an estimated 7.4 million Americans are currently living with Alzheimer’s disease in 2026, a number expected to rise significantly in the coming years.

The screenings are designed for individuals who may have concerns about their memory or the cognitive health of a loved one. Participating clinics will provide private assessments and opportunities to speak one-on-one with healthcare professionals about results, potential next steps, and available resources.

While memory screenings are not considered a formal diagnosis, health experts say early detection can help individuals access treatment options sooner, improve quality of life, and determine eligibility for clinical trials focused on slowing the progression of memory-related diseases.

In Dallas, screenings will be available through Kerwin Medical Center.

The initiative is being coordinated by the Global Alzheimer’s Platform Foundation, an international nonprofit organization focused on accelerating the development of Alzheimer’s treatments and neurological therapies. The organization supports more than 100 research sites worldwide and works to improve access, affordability, and diversity in Alzheimer’s and dementia-related clinical trials.

National Clinical Trials Day honors the medical advancements made possible through clinical research and recognizes the contributions of individuals who participate in trials that help drive innovation in healthcare.

Additional participating sites are located throughout Texas, including facilities in Beaumont and Rio Grande City, as well as dozens of locations nationwide in states such as Florida, Georgia, Illinois, Michigan, Missouri, Arizona, California, and Hawaii.

Appointments for screenings must be scheduled directly through participating locations.

For more information about participating research sites and Alzheimer’s clinical trial opportunities, visit Global Alzheimer’s Platform Foundation.